Viracta Therapeutics Inc (VIRX)
0.8299
+0.02
(+2.44%)
USD |
NASDAQ |
May 17, 16:00
0.8299
0.00 (0.00%)
After-Hours: 20:00
Viracta Therapeutics Net Income (Quarterly): -9.141M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.141M |
| December 31, 2023 | -13.76M |
| September 30, 2023 | -12.60M |
| June 30, 2023 | -12.48M |
| March 31, 2023 | -12.21M |
| December 31, 2022 | -10.33M |
| September 30, 2022 | -17.74M |
| June 30, 2022 | -10.58M |
| March 31, 2022 | -10.55M |
| Date | Value |
|---|---|
| December 31, 2021 | -11.45M |
| September 30, 2021 | -14.91M |
| June 30, 2021 | -9.17M |
| March 31, 2021 | -79.23M |
| December 31, 2020 | -6.285M |
| September 30, 2020 | -4.079M |
| June 30, 2020 | -4.236M |
| March 31, 2020 | -4.417M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-79.23M
Minimum
Mar 2021
-4.079M
Maximum
Sep 2020
-14.30M
Average
-10.58M
Median
Jun 2022
Net Income (Quarterly) Benchmarks
| XOMA Corp | -8.595M |
| Organovo Holdings Inc | -3.604M |
| Marinus Pharmaceuticals Inc | -38.67M |
| Cartesian Therapeutics Inc | -56.82M |
| Adial Pharmaceuticals Inc | -1.920M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 13.88M |
| EPS Diluted (Quarterly) | -0.23 |
| Enterprise Value | 16.26M |
| Earnings Yield | -152.4% |